Brian Thomas, Metagenomi CEO

Io­n­is part­ners up with Metageno­mi on drug dis­cov­ery pact, shelling out $80M up­front

Io­n­is is no stranger to large deals and work­ing with oth­er en­ti­ties, but its lat­est deal will see the com­pa­ny work Metageno­mi to go af­ter the liv­er.

The pair will con­duct re­search to de­liv­er up to four ge­net­ic tar­gets, with Io­n­is hav­ing the right to add four ad­di­tion­al tar­gets once cer­tain mile­stones have been hit. The terms of the agree­ment have Io­n­is pay­ing $80 mil­lion up­front to Metageno­mi, plus the po­ten­tial for fu­ture mile­stone pay­ments, which re­main undis­closed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.